CN Patent

CN101919811A — 一种左乙拉西坦注射液及其制备方法

Assigned to Shanghai Chenpon Pharmaceutical Technology Co Ltd · Expires 2010-12-22 · 15y expired

What this patent protects

本发明公开了一种左乙拉西坦注射液及其制备方法，本发明的左乙拉西坦注射液是由左乙拉西坦原料与不同盐的缓冲溶液组合，在pH值为5.0～6.0时，该液体制剂稳定性最好，治疗效果最佳。

USPTO Abstract

本发明公开了一种左乙拉西坦注射液及其制备方法，本发明的左乙拉西坦注射液是由左乙拉西坦原料与不同盐的缓冲溶液组合，在pH值为5.0～6.0时，该液体制剂稳定性最好，治疗效果最佳。

Drugs covered by this patent

Patent Metadata

Patent number
CN101919811A
Jurisdiction
CN
Classification
—
Expires
2010-12-22
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Chenpon Pharmaceutical Technology Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.